Cargando…
Phase II study of adjuvant chemotherapy with pemetrexed and cisplatin with a short hydration method for completely resected nonsquamous non‐small cell lung cancer
BACKGROUND: Cisplatin (CDDP) and vinorelbine as an adjuvant chemotherapy improve the overall survival of patients with completely resected non‐small cell lung cancer (NSCLC). However, the treatment completion rate is low due to severe adverse events (AEs). Pemetrexed (PEM) has been used in advanced...
Autores principales: | Tachihara, Motoko, Dokuni, Ryota, Okuno, Keiko, Tokunaga, Shuntaro, Nakata, Kyosuke, Katsurada, Naoko, Yamamoto, Masatsugu, Nagano, Tatsuya, Kobayashi, Kazuyuki, Tanaka, Yugo, Funada, Yasuhiro, Maniwa, Yoshimasa, Nishimura, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471012/ https://www.ncbi.nlm.nih.gov/pubmed/32729237 http://dx.doi.org/10.1111/1759-7714.13567 |
Ejemplares similares
-
Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
por: Katsurada, Naoko, et al.
Publicado: (2020) -
Effect of Bronchial Thermoplasty on Air Trapping Assessed by Xenon Ventilation Computed Tomography
por: Dokuni, Ryota, et al.
Publicado: (2021) -
Caspase Recruitment Domain-Containing Protein 9 Expression is a Novel Prognostic Factor for Lung Adenocarcinoma
por: Miwa, Nanako, et al.
Publicado: (2020) -
High expression level of serpin peptidase inhibitor clade E member 2 is associated with poor prognosis in lung adenocarcinoma
por: Dokuni, Ryota, et al.
Publicado: (2020) -
Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines
por: Effendi, Wiwin Is, et al.
Publicado: (2019)